Vectibix is not indicated for the treatment of patients with colorectal cancer that harbor somatic ras mutations in exon 2 codons 12 and, exon 3 codons 59 and 61, and exon 4 codons 117 and 146 of either kras or nras and hereafter is referred to as. Two main classes of anticancer agents affect the egfr. Xgeva includes the same active ingredient denosumab found in prolia. Cetuximab, a chimeric monoclonal antibody directed against the epidermal growth factor receptor egfr, is approved by the food and drug administration for the treatment of squamous cell carcinoma of the head and neck scchn. In patients with recurrent andor metastatic squamous cell cancer of the head and neck, cetuximab is used in combination with platinumbased chemotherapy followed by cetuximab as maintenance. Dec 01, 2019 erbitux provides approximately 22% higher exposure compared to this product. Closely monitor serum electrolytes, including serum magnesium, potassium, and calcium, during and after erbitux administration. Wildtype ras is a cancer without mutations in the kras and nras genes.
A faslodex 250 mg starting dose is recommended for patients with moderate hepatic impairment childpugh class b 1. One patient with no prior history of coronary artery disease died one day after the last dose of erbitux. Highlights of prescribing information these highlights do not. Hepatotoxicity and embryofetal toxicity 1 indications and usage 2 dosage and administration 3 dosage forms and strengths 4 contraindications 5 warnings and precautions 5. Approximately 90% of severe infusion reactions with cetuximab were observed during the first infusion. Each vial contains either mitomycin 5 mg and mannitol 10 mg, or mitomycin 20 mg and mannitol 40 mg, or mitomycin 40 mg and mannitol 80 mg. Because faslodex is an injection administered by a health care professional, you can confirm that your patients are. Cetuximab erbitux american journal of neuroradiology. Risk factors for and premedications to prevent cetuximab.
Highlights of prescribing information these highlights do not include all the information needed to use erbitux safely and effectively. Cetuximab binds to the egfr with an affinity that is approximately 5 to 10fold higher than that of endogenous ligands. Erbitux is indicated for the treatment of patients with squamous cell cancer of the head and neck. Erbitux 5mgml solution for infusion summary of product. Dermatologic toxicity related to cetuximab was managed according to the package insert. Page 1 of 18 erbituxtm rx only 1 2 cetuximab 3 for intravenous use only. Australian product information erbitux cetuximab rmc solution for injection intravenous infusion 1. Vectibix panitumumab for metastatic colorectal cancer. Erbitux reference guide for safe and effective use from the american society of healthsystem. In accordance with the statement on the package insert, the initial dose of cetuximab was administered at 400 mgm 2 over 2 h followed by weekly infusions of 250 mgm 2 over 1 h. Camptosar injection must be diluted prior to infusion. The overall rate of grade 3 or higher hypersensitivity reaction was 1.
Camptosar injection 20 mgml is intended for single use only and any unused portion should be discarded. Information for the user 78721852 erbitux 5 mgml solution for infusion cetuximab read all of this leaflet carefully before you start using this medicine because it contains important information for you. Faslodex 500 mg is administered as the same dose whether it is used as monotherapy or in combination with ribociclib, palbociclib, or abemaciclib 1. Highlights of prescribing information these highlights do. Cetuximab has been designed to attach to egfr, which can be found on the surface of some tumour cells.
Overexpression of the epidermal growth factor receptor egfr is correlated with poor prognosis in many human cancers. Full prescribing information 1 indications and usage zinplavais indicated to reduce recurrence of clostridium difficile infectioncdi in patients 18 years of age or older who are receiving antibacterial drug treatment of cdi and are at a high risk for cdi recurrence. Information for the user erbitux 5mgmlsolution for infusion cetuximab read all of this leaflet carefully beforeyou start using this medicinebecause it contains important information for you. Fatal infusionrelated reactions within 24 hours of rituxan infusion. Cetuximab erbitux is a mousehuman chimeric monoclonal antibody that targets. Severe infusion reactionsoccurred with the administration of 6 erbitux in approximately 3% of patients, rarely with fatal outcome package leaflet. Accordingly, the japanese package insert for cetuximab recommends premedication with an antihistamine and corticosteroid, and 88. Cyclophosphamide is a synthetic antineoplastic drug chemically related to the nitrogen mustards. Erbitux, inncetuximab european medicines agency europa eu. Managing premedications and the risk for reactions to. Apr 18, 2019 cetuximab or cetuximab irinotecan for egfrexpressing metastatic disease iv initial cetuximab dose of 400 mgm 2, followed by 250 mgm 2 once weekly until disease progression or unacceptable toxicity occurs. Niosh list of antineoplastic and other hazardous drugs in. As there were no data available on the efficacy and safety of cetuximab in combination with oxaliplatinbased regimens at the beginning of the surveillance in japan. As a firsttime treatment given with chemotherapy called folfox folinic acid, fluorouracil.
Highlights of prescribing information these highlights. Erbitux fda prescribing information, side effects and uses. Intrathecal administration of other vinca alkaloids has resulted in death. In extreme, fatal cardiac disorders andor sudden death occurred in 3% of the 219 patients with squamous cell carcinoma of the head and neck treated with a cetuximab product in combination with platinumbased therapy and fluorouracil. Ocular toxicity related to cetuximab monotherapy in patients. Learn about sylvant siltuximab, a prescription medicine administered by infusion iv therapy. Cetuximab is a recombinant chimeric monoclonal antibody that binds to the human epidermal growth factor receptor.
All the reagents and wash solutions should be used within 12 months from manufacturing date. Qualitative and quantitative composition each 20 ml vial contains 100 mg cetuximab. For patients experiencing radiationrelated esophagitis of grade. Use of erbitux is not indicated for the treatment of colorectal cancer in. Cd52 is expressed on the surface of normal and malignant b and t lymphocytes, nk cells, monocytes, macrophages, and tissues of the male. Monitor serum electrolytes, including serum magnesium, potassium, and calcium, during and after erbitux administration see warnings and precautions 5. Cetuximab was administered intravenously at a dosage of 400 mgm 2 initial dose, followed by 250 mgm 2 weekly. It further induces the internalisation of egfr, which can lead to downregulation of egfr. In combination with radiation therapy for the initial treatment of a certain type of locally or regionally advanced head and neck cancer. Erbitux cetuximab metastatic colorectal cancer and.
Low rate of cetuximab hypersensitivity reactions in. I f you have any further questions, ask your doctor. Full prescribing information 1 indications and usage jardiance is indicated. Ocular toxicity related to cetuximab monotherapy in. Camptosar should be diluted in 5% dextrose injection, usp, preferred or 0. Vectibix panitumumab is for treating patients with wildtype ras metastatic colorectal cancer cancer that has spread outside of the colon and rectum. Highlights of prescribing information before initiating. Rituxan rituximab for ra, nhl, cll, gpa, mpa, and pv. The most serious adverse event due to cetuximab is an infusion reaction ir. In general, cetuximab is well tolerated, and the most common toxicity is related to the skin. Highlights of prescribing information these highlights do not include all the information needed to use arzerra safely and effectively. Find information about rituxan rituximab, a possible treatment for ra, nhl, cll, gpa, mpa, and pv. A monoclonal antibody is an antibody a type of protein that has been designed to recognise and attach to a specific structure called an antigen in the body.
Scchn receiving erbitux with radiation therapy or a cetuximab product with platinumbased. Mitomycin for injection is a sterile dry mixture of mitomycin and mannitol, which, when reconstituted with sterile water for injection, provides a solution for intravenous administration. Cetuximab erbitux, a recombinant humanmouse chimeric monoclonal antibody, has been approved by the fda for use in patients with locally advanced scchn and in combination with irinotecan for the treatment of metastatic colorectal cancer. Infusion reactions are typically mild to moderate in intensity, develop during the infusion or several hours thereafter, and are most commonly associated with a complex of chills. Serious infusion reactions occurred with the administration of erbitux in approximately 3% of patients in clinical trials, with fatal outcome reported in less than 1 in. Serious infusion reactions and cardiopulmonary arrest infusion reactions. Dosing and administration faslodex fulvestrant injection. Data from the first infusion of cetuximab were collected for a total of 71 patients with various malignancies. Cyclophosphamide for injection, usp rx only description cyclophosphamide for injection, usp is a sterile white powder containing cyclophosphamide monohydrate.
Cetuximab blocks binding of endogenous egfr ligands resulting in inhibition of the function of the receptor. Reactions may include hypotension, dyspnea, upper airway edema, lip swelling, rash, pruritus, and urticaria. Japanese postmarketing surveillance of cetuximab erbitux. See important safety including boxed warnings for more information. Empliciti elotuzumab for injection, for intravenous use initial u. Page 1 of 36 highlights of prescribing information these highlights do not include all the information needed to use perjeta safely and effectively. Phase ii study of combination chemotherapy with biweekly cetuximab and irinotecan for wildtype kras metastatic colorectal cancer. Navelbine vinorelbine tartrate injection should be administered under the supervision of a physician experienced in the use of cancer chemotherapeutic agents. Full prescribing information erbitux cetuximab warning. Erbitux cetuximab metastatic colorectal cancer and head. Requests for erbitux cetuximab may be approved if the following criteria are met. A read is counted each time someone views a publication summary such as the title, abstract, and list of authors, clicks on a figure, or views or downloads the fulltext. It is recommended to start cetuximab therapy one week before radiation therapy and to continue cetuximab therapy until the end of the radiation therapy period.
Monitor patients and discontinue rituxan infusion for severe reactions 5. This rate of 10%30% of delayed events in subsequent doses indicates the importance of close. Cetuximab is an epidermal growth factor receptor egfr inhibitor used for the treatment of metastatic colorectal cancer, metastatic nonsmall cell lung cancer and head and neck cancer. Cardiopulmonary arrest and hypomagnesemia 1 indications and usage 1. Australian product information erbitux cetuximab rmc. If you have any further questions, ask your doctor. Most cancer therapeuticsincluding cytotoxic agents and biologicscarry a risk for infusion reactions, which vary in symptom severity from mild flushing to potentially life.
Highlights of prescribing information perforation can occur. Arzerra ofatumumab injection, for intravenous use initial u. Highlights of prescribing information these highlights do not include all the information needed to use empliciti safely and effectively. Alternate dosing of cetuximab for patients with metastatic. The active substance in erbitux, cetuximab, is a monoclonal antibody. Cetuximab was detected in the amniotic fluid and in the serum of embryos from treated dams at gestation day 49. Severe mucocutaneous reactions, some with fatal outcomes 5. See full prescribing information for complete boxed warning. Closely monitor serum electrolytes, including serum magnesium, 16.
1036 879 1050 431 1067 801 1116 395 360 797 243 320 1151 870 449 463 192 899 1272 44 92 869 170 1253 1513 725 730 995 468 1331 924 751 783 1101 73 908 477